RETRA (CAS 1036069-26-7)

RETRA, or Restriction of Telomerase Reverse Transcriptase Activity, is a synthetic molecule used extensively in research to explain the role of telomerase in cellular aging and cancer. Telomerase, particularly its reverse transcriptase component hTERT, is pivotal in maintaining telomere length, which protects chromosome ends from deterioration or fusion with neighboring chromosomes. Telomeres naturally shorten with each cell division, and telomerase activity is crucial for extending the lifespan of cells, especially in stem cells and cancer cells, where telomere length is actively maintained to support continuous division. By inhibiting hTERT, RETRA accelerates telomere shortening, leading to potential cellular senescence or apoptosis, particularly in telomerase-dependent cancer cells. This mechanism makes RETRA a valuable tool in cancer biology research, providing insights into the potential vulnerabilities of cancer cells concerning telomere dynamics. Furthermore, RETRA′s role in these studies helps to deepen the understanding of telomerase as a target for cancer research, offering a window into the cellular mechanics of aging and proliferation. Through its application, researchers can dissect the impacts of reduced telomere length on cellular behavior, contributing significantly to the fields of molecular and cellular biology.